MUSTBIO

Private

SuwonHealthcare & Life Scienceshttp://mustbio.com/en/

Last Round

Series C

Mar 14, 2026

Est. Valuation

$63.1M

Total Funding Raised

$156.7M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

MUSTBIO is a biotechnology company that develops multi-specific antibody-based cancer immunotherapies using its proprietary BICSTA™ and STARKINE™ platforms.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Drug Discovery, Pharma Supply Chain

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

biotechnologybiochemical reagentsdrug discoverycustom synthesiscontract manufacturingbiologicsimmuno-oncologyantibody developmentlife science researchbiotech supply chainlab consumablesCDMOprotein engineeringin silico designpharma R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MUSTBIO Comps

Public and private peers based on sector, stage, and business model.

MUSTBIO comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

MUSTBIO Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series C	Mar 14, 2026
Series C	Mar 13, 2026
Follow-on Offering	Feb 10, 2025
Private Placement	Oct 25, 2024
Private Placement	Jun 21, 2024
Follow-on Offering	May 2, 2024

View all Funding Rounds

Key People

Founding team and executive leadership

김맹섭

Chief Executive Officer

Executive Team

MUSTBIO Investors

Notable investors and investment history

MUSTBIO investors
Investor	Rounds
Runway Growth Capital	Debt
ROTH Capital Partners	Follow-on Offering
National Cancer Institute	Grant
BNH INVESTMENT	Series C
Korea Investment Partners	Series C, Series B, Series A
NIH RADx	Grant
H.C. Wainwright & Co.	Private Placement, Follow-on Offering

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

May 20, 2026
Monthly visitors grew 95% MoM, from 3.2K to 6.2K.
Feb 10, 2025
Raised $8M in a follow-on offering.

View all signals

MUSTBIO Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

MUSTBIO Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MUSTBIO's valuation, stock price, and market status.

Firmographic Details

HeadquartersSuwon

Employee Range6

Year Founded2021

Last FundingMar 14, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.